We further analyzed the quantitative change in BCR-ABL P210 expression and found that the BCR-ABL P210 expression level was significantly elevated in the COVID-19 group compared with that in the non-COVID-19 group (P<0.001) (Figure 2A). The gene discussed is ABL1; the disease is COVID-19.